Jivi 500 Unit (Antihemophilic Factor (Recombinant, B-Domain Deleted, Pegylated) POWDER FOR SOLUTION) 500 UNIT

JIVI 500 Unit is a recombinant antihemophilic factor used for hemophilia B treatment. This intravenous powder for solution helps manage bleeding episodes and prevent surgical bleeding.

Strength

500 UNIT

Pack Size

500

Manufacturer / TM Owner

BAYER INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

JIVI 500 Unit is primarily used to control and prevent bleeding in individuals with hemophilia B, a condition characterized by a deficiency in clotting factor IX. This medication is designed to replace the missing clotting factor, thereby aiding in the formation of blood clots. It is often administered intravenously to manage bleeding episodes or to prevent bleeding during surgical procedures. The recombinant nature of JIVI ensures a high level of purity and reduces the risk of transmitting blood-borne infections.

Side Effects

Common effects of JIVI 500 Unit may include localized reactions at the injection site, such as redness, swelling, or discomfort. Some individuals might experience mild flu-like symptoms, including fever, chills, or fatigue. These effects are generally temporary and resolve on their own. Severe allergic reactions are rare but require immediate medical attention.

Precautions & Warnings

JIVI 500 Unit should be handled with care, ensuring proper storage and preparation to maintain its efficacy. It is crucial to follow the healthcare provider's instructions for administration and monitoring. Individuals with known allergies to any components of the medication should avoid its use. Regular monitoring of clotting factor levels may be necessary to adjust the dosage as needed.

Avoid Interactions

JIVI 500 Unit may interact with certain medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications, including over-the-counter drugs and supplements, before starting treatment. Alcohol consumption should be moderated, as it can affect the body's ability to clot blood. Always consult a healthcare professional for personalized advice.

Frequently Asked Questions

JIVI 500 Unit is used to control and prevent bleeding in individuals with hemophilia B.

JIVI 500 Unit is administered intravenously as a powder for solution.

Common side effects may include localized reactions at the injection site and mild flu-like symptoms.

Yes, JIVI 500 Unit can be used to prevent bleeding during surgical procedures.

Individuals with known allergies to any components of JIVI 500 Unit should avoid its use.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.